Browsing: Medication & Drugs

Eli Lilly’s Alzheimer’s drug approved in Japan

By 0

Eli Lilly gains approval for their Alzheimer’s drug donanemab (Kisunla) in Japan, offering another treatment targeting amyloid plaques like Eisai’s Leqembi as the ageing population drives a rise in dementia cases.

Health Rounds: Older eggs may be made suitable for IVF

By 0

Health Rounds: A study in mice suggested transplanting eggs from older ovaries into younger tissue could rejuvenate them and improve IVF outcomes. Researchers found a gene variant that protects some babies from jaundice by better processing bilirubin. A trial demonstrated Exelixis’ Cabometyx extended progression-free survival for patients with advanced pancreatic neuroendocrine tumours resistant to other treatments.

Press Release – Roche’s Tecentriq® SC (atezolizumab) becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Singapore, reducing treatment time to a few minutes

By 3
Roche announced today that Tecentriq® SC (atezolizumab) has been approved by the Singapore Health Sciences Authority (HSA) for all indications in which the intravenous (IV) formulation of Tecentriq has been previously approved, including certain types of lung, breast and liver cancer.4 Tecentriq SC is Roche’s fourth subcutaneous cancer therapy,5-7 and the world’s first injectable anti-PD-(L)1 cancer immunotherapy.

Log In or Register as a healthcare professional to read the full article.